The efficacy and tolerability of the slow-acting combined agent glucosamine and chondroitin sulfate in gonarthrosis patients tacking no nonsteroidal anti-inflammatory drugs
Objective: to evaluate the efficacy and tolerability of the combined symptomatic slow-acting combined agent Theraflex in gonarthrosis patients untreated with nonsteroidal antiinflammatory drugs (NSAIDs).Patients and methods. The investigation enrolled 84 patients (78 women and 6 men) aged 55.23±7.36...
Main Authors: | A. P. Rebrov, I. A. Romanova, I. Z. Gaydukova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2016-01-01
|
Series: | Современная ревматология |
Subjects: | |
Online Access: | https://mrj.ima-press.net/mrj/article/view/654 |
Similar Items
-
Cardiovascular safety and efficacy of the combined symptomatic slow-acting drug glucosamine and chondroitin sulfate in patients with gonarthrosis
by: A. P. Rebrov, et al.
Published: (2016-06-01) -
Basic symptom-modifying delayed-action drugs in therapy of osteoporosis
by: Vladimir Vasil'evich Badokin, et al.
Published: (2011-09-01) -
THE CORES A SYMPTOM-MODIFYING PREPARATIONS OF THE SLOWEDDOWN ACTION IN THERAPY OF OSTEOARTROSIS
by: V V Badokin, et al.
Published: (2010-04-01) -
Treatment in patients with osteoarthritis at different sites: Place of slow-acting drugs
by: N. V. Chichasova, et al.
Published: (2015-06-01) -
Chondroitin sulfate: the mechanisms of action, its efficacy and safety in the therapy of osteoarthrosis
by: S G Anikin, et al.
Published: (2012-09-01)